Noticias de Eulerpool Pfizer

Pfizer Noticias de Acciones

Pfizer es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Pfizer.

• 31 de mayo ·

  Yahoo
  Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
• 30 de mayo ·

  Yahoo
  Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%
• 30 de mayo ·

  Yahoo
  ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC
• 30 de mayo ·

  Yahoo
  Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
• 30 de mayo ·

  MarketWatch
  Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.
• 30 de mayo ·

  SeekingAlpha
  Pfizer's Oral Obesity Drug Flop - A Symptom Of A Deeper Pipeline Problem
• 30 de mayo ·

  Yahoo
  Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes
• 29 de mayo ·

  Yahoo
  Pfizer (NYSE:PFE) Ends Collaboration With Acepodia And Faces Depo-Provera Legal Challenges
• 29 de mayo ·

  MarketWatch
  Pfizer Inc. stock outperforms competitors on strong trading day
• 29 de mayo ·

  Yahoo
  Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound?